z-logo
open-access-imgOpen Access
Liver stiffness measured by magnetic resonance elastography in early recurrence of hepatocellular carcinoma after treatment
Author(s) -
Huimin Zhao,
Lijun Zhang,
Huadong Chen
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000026183
Subject(s) - medicine , magnetic resonance elastography , hepatocellular carcinoma , cochrane library , medline , confidence interval , meta analysis , elastography , hazard ratio , magnetic resonance imaging , carcinoma , subgroup analysis , radiology , oncology , ultrasound , political science , law
Background: With high diagnostic accuracy, magnetic resonance elastography (MRE) is a noninvasive tool and can be adopted to measure liver stiffness (LS). In this study, meta-analysis was carried out to further evaluate whether LS measured by MRE can predict early recurrence in patients with hepatocellular carcinoma (HCC). Methods: PUBMED, EMBASE, Web of Science, China National Knowledge Infrastructure, and Cochrane Library database were searched for studies related to LS measured by MRE in the prediction of recurrence in patients with HCC. Survival outcome was estimated by hazard ratios and 95% confidence intervals. Meta-analysis was conducted with the Stata 16.0. Results: The results of this meta-analysis will be submitted to a peer-reviewed journal for publication. Conclusion: This study will provide evidence support for LS measured by MRE in predicting the recurrence of HCC. Ethics and dissemination: The private information from individuals will not be published. This systematic review also should not damage participants’ rights. Ethical approval is not available. The results may be published in a peer-reviewed journal or disseminated in relevant conferences. OSF Registration Number: DOI 10.17605/ OSF.IO / SURH3.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here